![Erik Manting](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Manting
Vorstandsvorsitzender bei
MENDUS AB
Vermögen: - $ am 30.06.2026
Profil
Erik Manting is the founder of Bioentrepreneur BV, founded in 2017.
Current jobs include Independent Director at TransCode Therapeutics, Inc. since 2020, Chief Executive & Business Officer at Mendus AB since 2021, and Member-Supervisory Board at Synerkine Pharma BV since 2019.
Former jobs include Chief Executive Officer at DCPrime BV from 2017 to 2020,.
Executive Director-Life Sciences & Healthcare at Kempen & Co. NV from 2012 to 2017, and Analyst at Rabo Securities NV in 2005.
Education includes a doctorate from the University of Groningen.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.05.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Erik Manting
| Unternehmen | Position | Beginn |
|---|---|---|
| MENDUS AB | Vorstandsvorsitzender | 16.03.2021 |
| TRANSCODE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 20.12.2020 |
Synerkine Pharma BV
 Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Engages in developing fusion proteins for treatment of chronic pain and operates medical laboratories | Direktor/Vorstandsmitglied | 01.03.2019 |
Ehemalige bekannte Positionen von Erik Manting
| Unternehmen | Position | Ende |
|---|---|---|
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Vorstandsvorsitzender | 01.12.2020 |
Kempen & Co. NV
 Kempen & Co. NV Financial ConglomeratesFinance Provides financial services to professional investors | Corporate Officer/Principal | 01.09.2017 |
Rabo Securities NV
 Rabo Securities NV Investment Banks/BrokersFinance Operates a brokerage and trades securities | Analyst-Equity | 14.09.2005 |
Bioentrepreneur BV | Gründer | - |
Ausbildung von Erik Manting
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Kempen & Co. NV
Kempen & Co. NV Financial ConglomeratesFinance Provides financial services to professional investors | Finance |
Rabo Securities NV
Rabo Securities NV Investment Banks/BrokersFinance Operates a brokerage and trades securities | Finance |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Health Technology |
Mendus AB
 Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Engages in developing fusion proteins for treatment of chronic pain and operates medical laboratories | Commercial Services |
TransCode Therapeutics, Inc.
 TransCode Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes diagnostics and therapeutics for the detection and treatment of cancer | Health Technology |
Bioentrepreneur BV |
Wählen Sie MarketScreener 
